These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24683105)

  • 1. Pretransplant levels of endotoxin can predict the risk of bacterial infections and graft liver function after liver transplantation.
    Sanada Y; Urahashi T; Ihara Y; Okada N; Yamada N; Hirata Y; Mizuta K
    Eur J Pediatr Surg; 2015 Jun; 25(3):236-41. PubMed ID: 24683105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of endotoxin measured by an endotoxin activity assay during liver transplantation.
    Sanada Y; Mizuta K; Urahashi T; Ihara Y; Wakiya T; Okada N; Yamada N; Ushijima K; Otomo S; Sakamoto K; Yasuda Y; Kawarasaki H
    J Surg Res; 2013 Apr; 180(2):349-55. PubMed ID: 22677614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation.
    Marubashi S; Dono K; Nagano H; Asaoka T; Hama N; Kobayashi S; Miyamoto A; Takeda Y; Umeshita K; Monden M
    Liver Transpl; 2007 Nov; 13(11):1538-44. PubMed ID: 17969209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of treated bacterial infections within one month before living donor liver transplantation in adults.
    Hara T; Soyama A; Takatsuki M; Hidaka M; Carpenter I; Kinoshita A; Adachi T; Kitasato A; Kuroki T; Eguchi S
    Ann Transplant; 2014 Dec; 19():674-9. PubMed ID: 25536330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Pretransplant Infections on Clinical Course in Liver Transplant Recipients.
    Kim YJ; Yoon JH; Kim SI; Choi HJ; Choi JY; Yoon SK; You YK; Kim DG
    Transplant Proc; 2018 May; 50(4):1153-1156. PubMed ID: 29731084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients.
    Saner FH; Olde Damink SW; Pavlakovic G; van den Broek MA; Rath PM; Sotiropoulos GC; Radtke A; Canbay A; Paul A; Nadalin S; Malagó M; Broelsch CE
    Transplantation; 2008 Jun; 85(11):1564-8. PubMed ID: 18551060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for portal vein complications after pediatric living donor liver transplantation with left-sided grafts.
    Moon JI; Jung GO; Choi GS; Kim JM; Shin M; Kim EY; Kwon CH; Kim SJ; Joh JW; Lee SK
    Transplant Proc; 2010 Apr; 42(3):871-5. PubMed ID: 20430193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and criteria predicting early graft loss after adult-to-adult living donor liver transplantation.
    Du Z; Wei Y; Chen K; Chen X; Zhang Z; Li H; Ma Y; Li B
    J Surg Res; 2014 Apr; 187(2):673-82. PubMed ID: 24275573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation.
    Trotter JF; Mackenzie S; Wachs M; Bak T; Steinberg T; Polsky P; Kam I; Everson GT
    Transplantation; 2003 Feb; 75(4):473-6. PubMed ID: 12605112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):396-8. PubMed ID: 22410026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical effect of intraportal insulin administration on liver graft regeneration in adult patients underwent living donor right lobe liver transplantation.
    Xu MQ; Yan LN; Li B; Wen TF; Zeng Y; Zhao JC; Wang WT; Yang JY; Ma YK; Chen ZY; Zhang ZW
    Transplant Proc; 2009 Jun; 41(5):1698-702. PubMed ID: 19545710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four hundred thirty consecutive pediatric living donor liver transplants: variables associated with posttransplant patient and graft survival.
    Neto JS; Pugliese R; Fonseca EA; Vincenzi R; Pugliese V; Candido H; Stein AB; Benavides M; Ketzer B; Teng H; Porta G; Miura IK; Baggio V; Guimaraes T; Porta A; Rodrigues CA; Carnevale FC; Carone E; Kondo M; Chapchap P
    Liver Transpl; 2012 May; 18(5):577-84. PubMed ID: 22271646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased immunoglobulin G levels after living-donor liver transplantation is a risk factor for bacterial infection and sepsis.
    Yoshizumi T; Shirabe K; Ikegami T; Yamashita N; Mano Y; Yoshiya S; Matono R; Harimoto N; Uchiyama H; Toshima T; Maehara Y
    Transpl Infect Dis; 2014 Apr; 16(2):225-31. PubMed ID: 24593220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant neurological presentation and severe posttransplant brain injury in patients with acute liver failure.
    Tan WF; Steadman RH; Farmer DG; Hong JC; Busuttil RW; Apinyachon W; Xia VW
    Transplantation; 2012 Oct; 94(7):768-74. PubMed ID: 22936036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant bacteremia in adult living donor liver transplant recipients.
    Iida T; Kaido T; Yagi S; Yoshizawa A; Hata K; Mizumoto M; Mori A; Ogura Y; Oike F; Uemoto S
    Liver Transpl; 2010 Dec; 16(12):1379-85. PubMed ID: 21117247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of failure in living donor liver transplantation: differential outcomes in children and adults.
    Goldstein MJ; Salame E; Kapur S; Kinkhabwala M; LaPointe-Rudow D; Harren N P P; Lobritto SJ; Russo M; Brown RS; Cataldegirmen G; Weinberg A; Renz JF; Emond JC
    World J Surg; 2003 Mar; 27(3):356-64. PubMed ID: 12607066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation.
    Lin KH; Liu JW; Chen CL; Wang SH; Lin CC; Liu YW; Yong CC; Lin TL; Li WF; Hu TH; Wang CC
    PLoS One; 2013; 8(9):e72893. PubMed ID: 24023787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation.
    Yagi S; Iida T; Taniguchi K; Hori T; Hamada T; Fujii K; Mizuno S; Uemoto S
    Liver Transpl; 2005 Jan; 11(1):68-75. PubMed ID: 15690538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.